EB
VNDA icon

Eastern Bank’s Vanda Pharmaceuticals VNDA Stock Holding History

Eastern Bank’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.6K Hold
5,000
– – ﹤0.01% 700
2026
Q1 		$34.5K Hold
5,000
– – ﹤0.01% 631
2025
Q4 		$44.1K Hold
5,000
– – ﹤0.01% 596
2025
Q3 		$24.9K Hold
5,000
– – ﹤0.01% 682
2025
Q2 		$23.6K Hold
5,000
– – ﹤0.01% 655
2025
Q1 		$22.9K Hold
5,000
– – ﹤0.01% 668
2024
Q4 		$23.9K Hold
5,000
– – ﹤0.01% 666
2024
Q3 		$23.4K Buy
+5,000
New +$26.8K ﹤0.01% 662

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Eastern Bank's VNDA Position: Q2 2026 in Review

Eastern Bank held its Vanda Pharmaceuticals (VNDA) position steady in Q2 2026 at 5,000 shares worth $30.6K. The position accounts for ﹤0.01% of the portfolio, ranked #700.

Eastern Bank first reported a position in VNDA in Q3 2024 and has held it in 8 quarters since. The position peaked at $44.1K in Q4 2025. 173 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Eastern Bank held 5,000 shares of Vanda Pharmaceuticals worth $30.6K as of Q2 2026.
  • Eastern Bank left its Vanda Pharmaceuticals share count unchanged in Q2 2026.
  • Vanda Pharmaceuticals made up ﹤0.01% of Eastern Bank's portfolio in Q2 2026, its #700 holding.
  • Eastern Bank first reported a position in Vanda Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • Eastern Bank's Vanda Pharmaceuticals position peaked at $44.1K in Q4 2025.
  • 173 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.